‘A Complete Overview of Pulmonary Function Tests’ launched at RESPICON

New Delhi: RESPICON 2024 organised between 27th and 29th September witnessed a significant milestone in the field of pulmonary medicine with the launch of the highly anticipated book, “A Complete Overview of Pulmonary Function Tests: From Basic Principles to Advanced Techniques.”

The book was officially released by the revered spiritual leader, Param Pujya Dr. Swami Divyanand Ji Maharaj, during a special ceremony held on the first day of the conference.

The author, Prof. Dr. Rupak Singla, HoD, NITRD, expressed his profound gratitude and pride on this occasion. He stated, “It is with great pride and immense gratitude that I am releasing my book at RESPICON 2024. This book is the result of years of research and clinical experience, reflecting my dedication to advancing pulmonary medicine. My aim has always been to make complex scientific concepts easier to understand and apply in daily clinical practice. I hope this book will be a useful guide for clinicians, researchers, and students, helping them feel confident in using pulmonary function tests. As we continue to face new challenges in respiratory care, I sincerely hope this book helps improve patient outcomes and the quality of care we provide. Our goal is to improve the overall lung health of our patients.”

The book, described as a comprehensive resource, delves into the intricacies of pulmonary function tests, offering insights from basic principles to advanced techniques. It is designed to serve as a vital tool for healthcare professionals, enhancing their understanding and application of these essential diagnostic tests.

Dr. Rakesh K. Chawla, the Organizing Chairman and Dr Aditya Chawla, Organising Secretary of RESPICON 2024, also shared their thoughts on the book launch. They remarked, “The release of this book marks a significant advancement in our field. Prof. Dr. Rupak Singla ‘s work is not only a testament to his expertise but also a valuable contribution to pulmonary medicine. This book is poised to become an indispensable resource for anyone involved in respiratory care. It aligns perfectly with the objectives of RESPICON, which is to bring the latest knowledge and innovations to the forefront of clinical practice. We are proud to host this launch at our conference.”

The event was attended by a distinguished audience of medical professionals, researchers, and students from across the country and beyond. The launch of this book is expected to have a lasting impact on the field of respiratory medicine, particularly in the area of pulmonary function testing.

Related Posts

Brain organoid maturation is driven by a lifelike developmental clock: Study

A National Institutes of Health (NIH)-funded scientific team has shown that under the right circumstances, 3D cell culture models of human brain tissue, known as organoids, can express features of…

Delhi Police Bust ₹9-Crore Interstate Cancer Drug Diversion Network: 17 Arrested; 588 Anti-Cancer Vials, ₹50 Lakh Cash Seized

New Delhi: The Delhi Police Crime Branch has busted a major interstate syndicate allegedly involved in the illegal procurement, diversion, storage, repackaging and sale of counterfeit and illegally obtained high-value…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Brain organoid maturation is driven by a lifelike developmental clock: Study

Brain organoid maturation is driven by a lifelike developmental clock: Study

Delhi Police Bust ₹9-Crore Interstate Cancer Drug Diversion Network: 17 Arrested; 588 Anti-Cancer Vials, ₹50 Lakh Cash Seized

Delhi Police Bust ₹9-Crore Interstate Cancer Drug Diversion Network: 17 Arrested; 588 Anti-Cancer Vials, ₹50 Lakh Cash Seized

‘Smart’ Cancer Drug RK-251 Developed by Indian Scientists Could Offer Targeted Alternative to Chemotherapy

‘Smart’ Cancer Drug RK-251 Developed by Indian Scientists Could Offer Targeted Alternative to Chemotherapy

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000